Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ADMA BIOLOGICS, INC. Director's Dealing 2021

Oct 19, 2021

31261_dirs_2021-10-18_38d0746f-ecb2-4af7-b8bb-b23383be78b9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ADMA BIOLOGICS, INC. (ADMA)
CIK: 0001368514
Period of Report: 2021-10-15

Reporting Person: KWON YOUNG (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 100000 Direct